Your browser doesn't support javascript.
loading
Globe size and bevacizumab treatment in retinopathy of prematurity: should we adjust the dose?
Connor, A J; Shafiq, A.
Affiliation
  • Connor AJ; Newcastle Eye Centre, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
  • Shafiq A; Newcastle Eye Centre, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
Eye (Lond) ; 30(11): 1401-1403, 2016 Nov.
Article in En | MEDLINE | ID: mdl-27472209
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retinopathy of Prematurity / Angiogenesis Inhibitors / Axial Length, Eye / Bevacizumab Type of study: Observational_studies Limits: Humans / Infant / Newborn Language: En Journal: Eye (Lond) Journal subject: OFTALMOLOGIA Year: 2016 Document type: Article Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retinopathy of Prematurity / Angiogenesis Inhibitors / Axial Length, Eye / Bevacizumab Type of study: Observational_studies Limits: Humans / Infant / Newborn Language: En Journal: Eye (Lond) Journal subject: OFTALMOLOGIA Year: 2016 Document type: Article Country of publication: Reino Unido